These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22365626

  • 1. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation.
    Hatakenaka M, Yonezawa M, Nonoshita T, Nakamura K, Yabuuchi H, Shioyama Y, Nagao M, Matsuo Y, Kamitani T, Higo T, Nishikawa K, Setoguchi T, Honda H.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e67-73. PubMed ID: 22365626
    [Abstract] [Full Text] [Related]

  • 2. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.
    Anticancer Res; 1999 May 01; 19(5C):4463-7. PubMed ID: 10650793
    [Abstract] [Full Text] [Related]

  • 3. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 4. Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer.
    Chen PC, Chen YC, Lai LC, Tsai MH, Chen SK, Yang PW, Lee YC, Hsiao CK, Lee JM, Chuang EY.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1996-2003. PubMed ID: 21596488
    [Abstract] [Full Text] [Related]

  • 5. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e593-9. PubMed ID: 21658851
    [Abstract] [Full Text] [Related]

  • 6. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):656-64. PubMed ID: 15708243
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 8. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 9. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer.
    Abou-Jawde RM, Mekhail T, Adelstein DJ, Rybicki LA, Mazzone PJ, Caroll MA, Rice TW.
    Chest; 2005 Jul 01; 128(1):250-5. PubMed ID: 16002943
    [Abstract] [Full Text] [Related]

  • 10. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ.
    J Natl Cancer Inst; 2011 Dec 07; 103(23):1761-70. PubMed ID: 22056739
    [Abstract] [Full Text] [Related]

  • 11. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS, Chung WK, Ahn SJ, Nam TK, Nah BS, Song JY, Lim SC, Lee JK.
    Acta Otolaryngol; 2008 May 07; 128(5):590-6. PubMed ID: 18421617
    [Abstract] [Full Text] [Related]

  • 12. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE.
    Gynecol Oncol; 2007 Jan 07; 104(1):58-63. PubMed ID: 16919718
    [Abstract] [Full Text] [Related]

  • 13. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE, Johnson DB, Barilla F, Blackwell GG, Orr R, Roney M, Stanley AW, Pohost GM, Dell'Italia LJ.
    Am Heart J; 1998 Aug 07; 136(2):269-75. PubMed ID: 9704689
    [Abstract] [Full Text] [Related]

  • 14. [Assessment of global and regional left ventricular function with a 16-slice spiral-CT using two different software tools for quantitative functional analysis and qualitative evaluation of wall motion changes in comparison with magnetic resonance imaging].
    Koch K, Oellig F, Kunz P, Bender P, Oberholzer K, Mildenberger P, Hake U, Kreitner KF, Thelen M.
    Rofo; 2004 Dec 07; 176(12):1786-93. PubMed ID: 15573290
    [Abstract] [Full Text] [Related]

  • 15. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellavita R, Morganti AG, La Torre G, Trodella L, Genovesi D, Portaluri M, Maurizi-Enrici R, Barbera F, Maranzano E, Lupattelli M.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):403-12. PubMed ID: 17919844
    [Abstract] [Full Text] [Related]

  • 16. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1335-42. PubMed ID: 18922648
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M.
    Cancer Chemother Pharmacol; 2010 Sep 01; 66(4):729-36. PubMed ID: 20033810
    [Abstract] [Full Text] [Related]

  • 18. A matched-case comparison to explore the role of consolidation chemotherapy after concurrent chemoradiation in cervical cancer.
    Choi CH, Lee YY, Kim MK, Kim TJ, Lee JW, Nam HR, Huh SJ, Lee JH, Bae DS, Kim BG.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1252-7. PubMed ID: 21075554
    [Abstract] [Full Text] [Related]

  • 19. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
    Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG.
    Cancer; 2006 Sep 01; 107(5):967-74. PubMed ID: 16874819
    [Abstract] [Full Text] [Related]

  • 20. [Effect of low dobutamine doses dobutamine on left ventricular diastolic flow parameters in subjects with a low ejection fraction].
    Wojtarowicz A, Kaliszczak R, Płońska E, Puchała M, Drechsler D.
    Przegl Lek; 2002 Sep 01; 59(8):577-9. PubMed ID: 12638323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.